BIOCON SDN

Company Type: Manufacturer (Factory)

Company Introduction:

Biocon Sdn Bhd is the Malaysian subsidiary of Biocon Limited, a leading global biopharmaceutical company headquartered in India. Established in Malaysia, Biocon Sdn Bhd operates a state-of-the-art, large-scale integrated insulins manufacturing facility. This facility is dedicated to the production of high-quality biopharmaceutical products, predominantly recombinant human insulin (rh-insulin) and insulin analogs. The company plays a crucial role in providing affordable and accessible biosimilar insulins to patients worldwide, serving both domestic and international markets. Biocon Sdn Bhd is committed to research, development, and manufacturing excellence, adhering to stringent international regulatory standards to ensure the safety and efficacy of its products.

BIOCON SDN BHD (Malaysia) manufactures or sells products primarily within the biosimilar and biopharmaceutical categories. Their portfolio includes:

Biosimilar Insulins

Insulin Glargine

Recombinant Human Insulin

Insulin Aspart

Biosimilar Oncology Products

Trastuzumab

Bevacizumab

Pegfilgrastim

Biosimilar Autoimmune Products

Adalimumab

Other Biologics and APIs (Active Pharmaceutical Ingredients) for global distribution.